Home » Newsletters » BioWorld Science

BioWorld Science

March 24, 2020

View Archived Issues

Sorrento develops Covidtrap protein for potential prevention and treatment COVID-19

BET on BD1 for cancer, BD2 for inflammation

Recruiting NK cells to the antitumor battle

AnHeart receives clinical trial authorization for taletrectinib in China

European Commission approves intravenous formulation of Akynzeo

FDA approves phase III study of Actemra in patients with severe COVID-19 pneumonia

First-in-human study of PLN-1474 for the treatment of liver fibrosis

Phase I data for influenza vaccination with a high-density microarray patch

Phase II data presented for intratumoral tavokinogene telseplasmid in metastatic melanoma

Researchers identify lncRNA RPL34-AS1 as potential therapeutic target in esophageal cancer

Arena Pharmaceuticals patents S1P1 agonists

Antibody gene therapy with AAV8-VRC07 appears feasible in HIV patients

Birdie Biopharmaceuticals discloses new imidazoquinoline derivatives

Pipeline Therapeutics identifies muscarinic M1 receptor antagonists

Achillion Pharmaceuticals presents complement factor D inhibitors

New eiF4E inhibitors presented by Pic Therapeutics

Biomedical R&D takes hit as university labs, trials shut down due to COVID-19

New MAb increases the effects of PF4 in sepsis, stabilizing NETs and enhancing microbial entrapment

AveXis releases new data from phase I/II study of intrathecal AVXS-101 in SMA type 2

Milestone reports phase III topline data on at-home use of etripamil for PSVT

Ascentage doses first U.S. patient in global study of APG-2575 for relapsed/refractory CLL/SLL

Synthon studies ADC SYD-1875 in first-in-human study for locally advanced or metastatic cancer

14,15-DHET is a marker of doxorubicin-related cardiotoxicity

USP28 regulates deltaNp63 protein abundance in squamous cell carcinoma and can be a druggable target

Popular Stories

Today's news in brief
BioWorld
BioWorld briefs for May 12, 2026.
News in brief
BioWorld Asia
BioWorld Asia briefs for May 12, 2026
Alzheimer’s, beyond the brain
BioWorld
Researchers at Daping Hospital in China have reported that liver-targeted delivery of the APOE3-Christchurch (APOE3Ch) variant, a rare protective form of...
First cruise ship hantavirus genome points to zoonotic spillover
BioWorld
The initial appraisal of the first complete genome sequence of a hantavirus isolated from a patient in Switzerland who was a passenger on the cruise ship MV...
APAC monitors hantavirus as Singapore isolates 2 from cruise ship
BioWorld
Singapore’s Communicable Diseases Agency on May 7 said that it isolated two residents for hantavirus testing after the individuals disembarked from an Atlantic...